Literature DB >> 15522922

Cardiovascular disease and psychological morbidity among rheumatoid arthritis patients.

G J Treharne1, E D Hale, A C Lyons, D A Booth, M J Banks, N Erb, K M Douglas, D L Mitton, G D Kitas.   

Abstract

OBJECTIVES: To examine whether patients with rheumatoid arthritis (RA) with co-morbid cardiovascular disease (CVD) have different psychological morbidity (and psychosocial risk factors for it) compared with RA patients without co-morbid CVD.
METHODS: Patients with RA and co-morbid CVD (n = 44; hypertension alone for n = 27) were compared with RA patients without CVD (n = 110). Differences in psychological morbidity (depression and anxiety) and psychosocial risk factors for this (arthritis self-efficacy, acceptance, social support and optimism) were examined while controlling statistically for medical and demographic covariates.
RESULTS: Groups did not differ on RA duration, RA activity, marital status or socioeconomic status, but RA patients with co-morbid CVD were older, less likely to be female and less likely to be in employment than those without CVD. RA patients with co-morbid CVD had significantly higher depression and were more likely to score above cut-offs for depression than RA patients without CVD. No differences existed in anxiety, although anxiety appeared to be more common than depression. Low optimism was identified as a possible psychosocial risk factor for depression.
CONCLUSIONS: RA patients with co-morbid CVD have higher depression than RA patients without CVD; low optimism is a potentially modifiable risk factor that may mediate this difference. RA patients with co-morbid CVD may benefit from systematic screening for depression and targeted intervention if necessary.

Entities:  

Mesh:

Year:  2004        PMID: 15522922     DOI: 10.1093/rheumatology/keh441

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  9 in total

1.  Differential Association of Psychosocial Comorbidities With Subclinical Atherosclerosis in Rheumatoid Arthritis.

Authors:  Ying L Liu; Moyses Szklo; Karina W Davidson; Joan M Bathon; Jon T Giles
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-10       Impact factor: 4.794

2.  Depression in patients with rheumatoid arthritis: description, causes and mechanisms.

Authors:  Mary Margaretten; Laura Julian; Patricia Katz; Edward Yelin
Journal:  Int J Clin Rheumtol       Date:  2011

3.  Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome.

Authors:  K M J Douglas; A V Pace; G J Treharne; A Saratzis; P Nightingale; N Erb; M J Banks; G D Kitas
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

Review 4.  Novel risk factors for cardiovascular disease in rheumatoid arthritis.

Authors:  Jenny Amaya-Amaya; Juan Camilo Sarmiento-Monroy; Ruben-Dario Mantilla; Ricardo Pineda-Tamayo; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

5.  Missed opportunities for depression screening in patients with arthritis in the United States.

Authors:  Mary E Margaretten; Patricia Katz; Gabriela Schmajuk; Edward Yelin
Journal:  J Gen Intern Med       Date:  2013-07-30       Impact factor: 5.128

6.  The underrated prevalence of depression in Japanese patients with rheumatoid arthritis - evidence from a Nationwide survey in Japan.

Authors:  Rosarin Sruamsiri; Yuko Kaneko; Jörg Mahlich
Journal:  BMC Rheumatol       Date:  2017-11-28

7.  A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post-hoc results from the certolizumab pegol phase 4 PREDICT trial.

Authors:  Jeffrey R Curtis; Christopher Herrem; 'Matladi N Ndlovu; Cathy O'Brien; Yusuf Yazici
Journal:  Arthritis Res Ther       Date:  2017-09-29       Impact factor: 5.156

8.  The multifaceted impact of anxiety and depression on patients with rheumatoid arthritis.

Authors:  Steve Peterson; James Piercy; Stuart Blackburn; Emma Sullivan; Chetan S Karyekar; Nan Li
Journal:  BMC Rheumatol       Date:  2019-10-28

Review 9.  Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors, Autoantibodies, and the Effect of Antirheumatic Therapies.

Authors:  Mir Sohail Fazeli; Vadim Khaychuk; Keith Wittstock; Boris Breznen; Grace Crocket; Mir-Masoud Pourrahmat; Leticia Ferri
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2021-06-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.